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Summary In this study, the role of parity in conferring protection of the mammary gland against chemical
carcinogenesis induced by 7,12-dimethylbenz(a)anthracene (DMBA) was investigated. Experiments were also
carried out to determine if an 'interrupted' pregnancy was capable of reducing the incidence of mammary
tumour induction. Since it has been suggested that morphological development or the proliferative pattern of
the mammary gland at the time of carcinogen administration may be involved in reducing the susceptibility of
the mammary gland to chemical carcinogenesis, experiments were designed to elucidate the possible influence
of these two factors. Sprague-Dawley female rats were mated and were either allowed to complete pregnancy
and parturition or were subjected to Caesarian section on day 5, 10 or 15 of the pregnancy. When DMBA
was administered i.v. to animals which had been allowed to complete a full-term pregnancy, only 14%
developed tumours, compared to 70% in age-matched nulliparous controls. Termination of the pregnancy on
days 5, 10 or 15 was as effective in reducing tumour incidence as full-term gestation and parturition, but still
resulted in partial and statistically significant inhibition, compared to age-matched nulliparous controls. There
was no significant difference in 3H-thymidine labelling index (LI) at the time of DMBA treatment in the
parous rats compared to age-matched nulliparous controls. We also observed no significant differences in the
morphological development of the mammary gland in parous and nulliparous rats of the same age. These
results indicate that the protective mechanism may not lie in the mammary gland per se, but may indeed be a
host factor, such as hormonal or immunological changes occurring in the host as a result of the pregnancy.
Epidemiologic observations have indicated that early full-
term pregnancy renders breast tissue less susceptible to the
action of a carcinogen (MacMahon et al., 1973; Valaoras
et al., 1969) and late pregnancy and nulliparity have been
shown to be associated with a higher risk of breast cancer
(MacMahon et al., 1973; Wynder et al., 1960; Cutler, 1962).
However, the mechanism by which parity confers
refractoriness of the mammary gland to carcinogenesis is not
clearly understood, although the epidemiologic studies
demonstrating this effect have been mimicked, using experi-
mental animals (Dao & Pazik, 1981; Russo & Russo, 1980).
It has been shown that while nulliparous rats are susceptible
to mammary carcinogenesis by 7,12-dimethylbenz[a]-
anthracene (DMBA), parous rats of the same age are
protected against the effect of the carcinogen. However, the
relative importance of two factors, i.e., the age at which first
pregnancy occurs and whether or not a full-term pregnancy
is required to achieve the most effective degree of inhibition,
remains unclear. Earlier reports from our laboratory have
demonstrated that early full-term pregnancy in rats induced
total protection of the mammary gland against carcino-
genesis. The purpose of the present study was to further
extend our investigation to elucidate the possible mechanism
by which pregnancy inhibits mammary carcinogenesis, and
to determine if a full-term pregnancy was required to induce
refractoriness of the mammary gland.
Materials and methods
Female and male Sprague-Dawley rats were obtained from
Harlan Sprague-Dawley (Madison, WI) for this study. The
animals were maintained in a temperature-controlled
(24+ 1°C) room with a daily cycle of 14h light and 10h
darkness. Females between the ages of 40-50 days were
allowed to mate with 90-day-old male rats, three females
being housed with one male. Mating started when the
females were 40 days old and no rats over the age of 49 days
were used for mating in these experiments. Vaginal smears
were taken daily to determine when conception had oc-
curred. The presence of a mucous plug or of sperm in the
smear was taken as an indication of the exact day of
conception. Pregnancy was subsequently confirmed by either
parturition or uterine examination at the time of Caesarean
-section.
When pregnancy was established, the pregnant rats were
placed in individual cages and divided into 5 groups. The
rats in group no. 1 were allowed to complete gestation and
parturition. The pups were removed at birth and the rats
were allowed to rest for 15 days in order for involution of
the mammary gland to occur. The animals in group no. 2
were treated similarly to those in group no. 1, except that
they were allowed to lactate for five days following delivery.
At the end of 5 days, the pups were removed and fifteen
days were allowed for involution of the mammary gland to
take place. In group no. 3, pregnancy was terminated by
Caesarean section on the 5th day of pregnancy. In groups
no. 4 and no. 5, pregnancy was terminated in the same
manner on day 10 and day 15 of pregnancy, respectively.
The animals in the three groups undergoing Caesarean
section were also allowed 15 days following termination of
the pregnancy, in order for involution of the mammary
gland to occur. At the end of the 15-day resting period, all
rats were given an i.v. injection of fat emulsion containing
DMBA (3mg-1 lOOg body wt). Controls were age-matched
nulliparous females treated in the same manner as the
parous rats. The animals were weighed and palpated weekly
for tumours. At 120 days after treatment with DMBA, all
animals were killed and autopsied, to determine if
nonpalpable tumours were present. Tumours were excised
and placed in Bouin's fixative for histological examination.
At the time of DMBA treatment, ten rats in each group,
including the nulliparous controls, were sacrificed and the
mammary glands fixed in alcohol-formalin-chloroform
fixative (Sinha & Pazik, 1981) for wholemount preparation.
The mammary labelling index was also determined at the
time of DMBA administration, in order to indicate the level
of DNA synthesis occurring in the gland at the time of
carcinogen treatment. Three rats from each group, including
the controls, were given an i.p. injection of 1 pCi 3H-
thymidine (50Cimmol-1, ICN Radiochemicals, Irvine, CA)
per gram body wt. Two hours later, the animals were
Correspondence: D.K. Sinha.
Received 7 July 1987; and in revised form, 21 October 1987.
Br. J Cancer (1988), 57, 390-394 C) The Macmillan Press Ltd., 1988PREGNANCY AND MAMMARY CARCINOGENISIS 391
sacrificed. The right and left inguinal mammary glands from
rats in oestrous were removed, fixed in Bouin's fluid and
paraffin sectioned for autoradiography. NTB 2 (Eastman
Kodak, Rochester, NY) was used to dip coat the slides.
Labelling index was determined by counting the labelled cells
compared to the total number of cells counted and was
expressed as a percentage. A minimum of 3000 cells were
counted from each gland. Statistical analysis was done either
by Student's 't' test or 'V' square, which is chi square test
corrected for sample size (Rhoades & Overall, 1982).
Results
Tumorigenesis
There were three sets of age-matched nulliparous control
rats. These rats had been placed in breeding cages with the
males, but had never become pregnant. The control rats
received DMBA at the ages of 69, 73 and 81 days, which
corresponded to the ages at which the parous rats received
the carcinogen. Of the 17 rats in group no. 5 (the 69-day
controls), 15 (88%) developed tumours. In controls given the
carcinogen at the age of 73 and 81 days, 18/21 (86%) and
26/27 (70%), respectively, developed tumours. Histologic
examination demonstrated all the tumours to be adeno-
carcinomas.
Two groups of rats were allowed to complete a full-term
pregnancy, but in one group, the rats were allowed to lactate
for 5 days following delivery. The pups were then removed
and the rats allowed to rest for 15 days prior to
administration of DMBA. We observed no significant
differences in tumorigenesis between the lactating or
nonlactating groups. Of the rats which became pregnant
between the ages of 40-46 days and were allowed to lactate
for 5 days after parturition, 5/30 (16.6%) developed
tumours. These rats were given DMBA at the age of 81
days. When similar rats without lactation were given
DMBA, 5/37 (13.5%) developed tumours. Difference
between these two groups were not statistically significant.
Both groups were significantly different from the age-
matched nulliparous controls, which demonstrated a 70%
rate of tumour induction.
In group 3, pregnancy was terminated on the fifth day of
pregnancy and the carcinogen was administered 15 days
later. In this group, 13/27 (48%) developed tumours. When
pregnancy was terminated on either day 10 or day 15,
followed by carcinogen administration 15 days later,
tumorigenesis was 12/24 (50%) and 14/31 (45%), respec-
tively, whereas the age-matched nulliparous controls had a
tumour incidence of 88% and 86%, respectively. This
difference was also statistically significant (Table I, Figure
1). These data indicate that full-term pregnancy results in the
greatest degree of tumour inhibition, since the incidence of
mammary tumorigenesis was reduced from 70% in the
controls to 14% in the full-term group. However, interrupted
pregnancy also appeared to confer some degree of
protection, since it resulted in a tumour incidence of 50%
and 45%, as compared to 88% and 86% in nulliparous age-
matched controls. There did not appear to be any discernible
difference if the pregnancy was terminated at day 5, 10 or 15.
Average tumours per tumour bearing rats in nulliparous
controls were 2.9 while in parous and parous lactating rats
were 2.6 and 2.0 respectively. In the 5, 10 and 15 days C-
section groups the average tumours/tumour bearing rats
were 2.5, 2.0 and 2.6. The difference in number of tumour
between groups was not statistically significant.
3H-thymidine labelling index
Table II summarizes the data on proliferative index of the
mammary gland at the time of carcinogen treatment in the
groups of animals described above. Since the rate of DNA
synthesis has been shown to play an important role during
carcinogenesis, we wished to determine if this factor was
involved in the induction of refractoriness in parous rats. We
found that the 3H-thymidine labelling index wag high in the
end buds of all groups used for these experiments, while that
in the alveoli was consistently low. However, as indicated in
Table II, there were no statistically significant differences in
labelling index between any of the parous groups, as
compared to the age-matched controls.
Morphology of the mammary gland
Wholemount preparations were made at the time of
carcinogen treatment in all groups. However, morphologic
examination did not reveal any significant differences
between the glands of parous and nulliparous animals of the
same age. All wholemounts showed areas of ductal
structures with club shaped end buds and areas where
alveolar buds were predominant. Few end buds were
observed in both types of glands, and the end buds appeared
to be localized only in certain areas of the gland. The major
part of the gland was composed of alveolar type of cells,
which is typical of rats at that age (Figures 2-7). For
numerical evaluation wholemount of 15 abdomino-inguinal
mammary glands each from full-term parous rats and their
age-matched nulliparous controls were evaluated. The end
buds and the alveolar buds were counted per mm2. This
examination did not reveal any significant difference between
the parous and nulliparous rats of same age. The mammary
glands from parous rats showed 9.73 (±1.28) end buds and
36.13 (±2.10) alveolar buds. The mammary glands from
nulliparous controls on the other hand showed 12.26
(± 1.20) end buds and 32.00 (± 2.10) alveolar buds per mm2.
The differences between the parous and nulliparous glands
were not statistically significant.
Table I Tumorigenesis in mammary gland of rats after full-term and incomplete pregnancy
Age at Age at DMBA No. of
No. of pregnancy treatment rats with
Term of pregnancy rats (days) (days) tumours Percent
5 days C-section 27 49 69 13 48.1
10 days C-section 24 45 70 12 50.0
15 days C-section 31 40 70 14 45.1
Full-term 37 46 81 5 13.5
Full-term/lactation 30 46 86 5 16.7
Age-matched control 17 - 69 15 88.2
Age-matched control 21 73 18 86.7
Age-matched control 37 81 26 70.3
P=Full-term vs. Full-term lactation, 0.88; 5 days C-section vs. control, 0.007; 10 days C-
section vs. control, 0.01; 15 days C-section vs. control, 0.03; Full-term vs. control, 0.004; Full-












Figure 1 Tumour incidence in the mammary gland of parous
rats after full-term (FT) or interrupted pregnancy. The numbers
5, 10 and 15 indicate the day on which pregnancy was
terminated. Solid blocks represent age-matched nulliparous
controls.
Figure 4
gland from parous rats showing predominantly ducts. Note the
darkly stained (club shaped) end buds. H&E (x25).
;unt from Figure 5
parous
riigure 2 Wholemount preparation of mammary gland from a
parous rat at the time of carcinogen administration (81 days
old). Note that the gland is mostly ductal, with some alveolar
buds and very few terminal end buds present. H&E (x 12).
Figure 6 Enlarged view of ductal area of the mammary
wholemount from age-matched virgin rats. H&E (x 25).
Figure 3 Wholemount preparation of mammary gland from an
81-day-old virgin rat. Note the similar morphological
organization to that of the mammary gland of the parous
animal, shown in Figure 2. The gland from the virigin animal is
likewise mostly ductal with some alveolar buds and very few
terminal end buds. H&E (x 12).
Figure 7 Enlarged area of an alveolar area from virgin control
rat. H&E (x25).
Table II 3H-Thymidine labelling index of mammary glands from virgin, incomplete and full-
term parous rats
Age at
Term of pregnancy labelling (days) End buds Alveoli Average
5 days C-sectiona 64 14.54+O.59b 0.54+0.20 7.54+0.38
Nulliparous controls 64 15.75+2.84 1.61+0.64 8.57+ 1.80
10 days C-sectiona 70 16.61+1.17 0.98+0.48 8.66+0.34
Nulliparous controls 70 11.30+0.93 1.64+0.38 6.47+0.63
Full-term 86 11.51+1.52 0.18+0.04 5.84+0.57
Nulliparous 86 10.32+ 1.88 0.58+0.04 5.27+0.62
aLabelling index was determined 15 days after termination of pregnancy or delivery. bS.e.m.
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Discussion
The present experiments demonstrated that when rats
completed a full-term pregnancy, mammary tumour
induction was significantly reduced. This finding is in
agreement with earlier studies by others (Cutler, 1962; Russo
& Russo, 1980). Our studies also showed no significant
difference in tumour incidence in the animals allowed to
lactate following parturition as compared to tumour
incidence in parous rats without lactation. Observations
from similar experiments have been reported by others
(Russo & Russo, 1980; Marchant, 1955; 1959). It should be
noted that Russo and Russo (1980) observed the presence of
more benign tumours in the groups of rats allowed to
lactate. Marchant (1955, 1959) observed total inhibition of
tumorigenesis in mice after lactation. None of these effects
were demonstrated in our studies.
An interesting observation in our investigation is that
termination of the pregnancy on day 5, 10 or 15 by
Caesarian section failed to abolish the inhibitory effect of
pregnancy on mammary tumour induction. In these rats,
there was partial, but still significant, inhibition of subse-
quent DMBA-induced carcinogenesis. This result is in
contradiction to the earlier work reported by Russo and
Russo (1980), and the reasons for this discrepancy are not
readily explained at this time. One possible explanation may
be that a larger number of animals were used in our
experiments, thus allowing us to observe an effect. Recent
epidemiologic studies in humans have also reported
conflicting results. Earlier investigations by Yuasa and
MacMahon (1970) and Ravinhar et al. (1979) suggested that
full-term pregnancy was required to achieve protection
against breast cancer, but this was not supported by the later
findings of Vessey et al. (1982). These authors have reported
that incomplete pregnancy (termination by abortion) did not
suppress the efficacy of pregnancy for protection of the
mammary gland against carcinogenesis in humans. It would
appear that our findings in experimental animals, in which
we observed a partial reduction in tumour incidence in
animals having incomplete pregnancy terminated by
Caesarian section, are similar to those in man.
The mechanism by which pregnancy protects the
mammary gland against carcinogenesis is not clearly
understood. Russo and Russo (1980) suggested that
morphological differentiation of the mammary gland confers
protection against carcinogenesis. These authors
hypothesized that during pregnancy terminal end buds and
ductal buds become differentiated into alveolar buds which
are known to be less susceptible to carcinogenesis. This
suggestion, however, was not supported by our present
findings, since we failed to observe any significant differences
in morphological differentiation between the parous rats and
their age-matched nulliparous counterparts. When
wholemount preparations from these two groups of animals
were compared, both showed the presence ofmostly alveolar
growth, and in both groups, there were very limited areas
showing few terminal end buds. It would seem that
predominately alveolar structure may be a characteristic of
age, rather than a consequence of pregnancy. It should be
noted that despite the similarities in morphology, the tumour
incidence in the nulliparous rats was significantly higher than
that in the age-matched parous animals.
The level of DNA synthesis at the time of carcinogen
treatment has been shown to be an important factor
influencing carcinogenesis (Lin et al., 1976; Nagasawa &
Vorherr, 1977). In the mitotically static mammary glands of
older rats, tumour incidence was low, whereas in vounger
rats having higher levels of DNA synthesis in the mammary gland, the tumour incidence was significantly higher (Sinha
et al., 1983). Acceleration of DNA synthesis in the mammary gland of older rats could overcome the refractory effect of
age, resulting in higher levels of tumour incidence (Sinha &
Dao, 1980). However, in the present study, the level of DNA
synthesis in the mammary gland of the parous rats at the
time of carcinogen treatment did not show a statistically
significant difference compared to that in nulliparous
animals, although there was a significant difference in
tumour incidence between the two groups. This was true for
both the full-term and incomplete pregnancy groups, when
compared to age-matched nulliparous controls. It appears
that neither morphological changes nor levels of DNA
synthesis in the mammary gland, as a result of pregnancy,
exert an inhibitory effect on mammary carcinogenesis.
Vonderhaar and Topper (1974) have shown that
pregnancy-type stimulation can produce a generation of cells
in a mammary gland, which, after the completion of one
mitotic cycle, continue to rest in the 'precritical' area of G1
phase. If these cells are further stimulated, they are not
obligated to go through a proliferative cycle; rather, they
enter the secretory phase directly. The mammary cells of
virgin female rats, on the other hand, rest in the 'postcritical'
area of G1 phase, and, upon further stimulation, are
obligated to go through a mitotic cycle. This hypothesis
would allow for meaningful interpretation of our data, since
DMBA is not only a mammary carcinogen, but it can also
stimulate mammary cells to replicate, as shown earlier by
Sinha and Dao (1980). Since the cells in a parous mammary
gland are resting in the 'precritical' area of G1, treatment
with DMBA would induce them to enter the secretory phase,
but cell proliferation would not occur, and, thus, the
neoplastic changes induced by the carcinogen would not be
expressed.
Another possible explanation that might account for the
lowered susceptibility of parous rats to chemical
carcinogenesis is the fact that immunological changes are
induced in the mother as a result of pregnancy. Conception
results from allogenic matings and the embryo is in effect an
'allograft' in the mother. Thus, foreign antigens have been
detected in embryos (Simmons & Russell, 1966; Heyner,
1973; Patthey & Edidin, 1973); in placental cells (Sellens et
al., 1978; Wegmann et al., 1979); and in trophoblasts (Loke
et al., 1971). One category of antigens, designated as
'oncofetal antigens', such as alpha foetoprotein, chorionic
gonadotropin, and chorionic somatomammotropin, also
result in stimulus to the mother. In addition, recent
investigations have revealed that several other antigens are
produced by both the foetus and/or placenta and also by
breast tumours. These would include pregnancy associated
alpha-2 glycoprotein (Sarcione et al., 1983); pregnancy-
specific beta-I glycoprotein (Grudzinskas et al., 1980);
placental lactogen (Monteiro et al., 1982); and placental
protein 5 (Bremner et al., 1981).
Thus, it appears reasonable to suggest that both foeto-
placental tissue and mammary tumours may produce some
antigens in common, against which the mother has been
immunized as a result of the pregnancy. This immunity may
well be maintained in the mother after the pregnancy has
been completed. It is our hypothesis that antibodies against
some specific substances produced by breast tumours, being
present in the parous female rat, are capable of recognizing
the newly transformed mammary cells and act against those
cells, thus providing an immunosurveillance mechanism
which would 'protect' the parous female rat against
subsequent tumour development. Our laboratory is now
investigating the possible mechanisms by which this might
occur.
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